Fujifilm accelerates the production of antiviral drug “Avigan Tablet” for COVID-19
FUJIFILM Corp. announced the expansion of its manufacturing capacity at FUJIFILM Toyama Chemical Co. Ltd. to significantly increase the production of its influenza antiviral drug “Avigan Tablet” for treating patients with COVID-19. To further boost the supply of Avigan, Fujifilm is also allocating additional capacity at its FUJIFILM Wako Pure Chemical Co. Ltd. facility in Japan, for the production of pharmaceutical intermediates used to manufacture...
Read More